

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 4.45590741 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.32135920 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.32135920 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.15313381 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.10181421 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 3.97797041 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97797041 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.96916640 |
| 9 | negative regulation of complement activation (GO:0045916) | 3.73345797 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.65038767 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.65038767 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.65038767 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.65038767 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.65038767 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.65038767 |
| 16 | detection of external biotic stimulus (GO:0098581) | 3.60125650 |
| 17 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.58703426 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 3.52630020 |
| 19 | detection of other organism (GO:0098543) | 3.52584414 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.51790823 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 3.50398197 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46057100 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.39559033 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39525435 |
| 25 | urea cycle (GO:0000050) | 3.37386641 |
| 26 | urea metabolic process (GO:0019627) | 3.37386641 |
| 27 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.34081008 |
| 28 | acylglycerol catabolic process (GO:0046464) | 3.32943516 |
| 29 | neutral lipid catabolic process (GO:0046461) | 3.32943516 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.31641025 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.31641025 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31531462 |
| 33 | negative regulation of humoral immune response (GO:0002921) | 3.28574742 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27963805 |
| 35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.27842400 |
| 36 | bile acid biosynthetic process (GO:0006699) | 3.25745555 |
| 37 | positive regulation of lipid catabolic process (GO:0050996) | 3.25329362 |
| 38 | cellular response to ethanol (GO:0071361) | 3.24372402 |
| 39 | triglyceride catabolic process (GO:0019433) | 3.22176136 |
| 40 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.21824506 |
| 41 | triglyceride homeostasis (GO:0070328) | 3.21603609 |
| 42 | acylglycerol homeostasis (GO:0055090) | 3.21603609 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 3.20562696 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.19690461 |
| 45 | macroautophagy (GO:0016236) | 3.18872960 |
| 46 | low-density lipoprotein particle clearance (GO:0034383) | 3.15432830 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13401574 |
| 48 | glutamate metabolic process (GO:0006536) | 3.13107567 |
| 49 | microglial cell activation (GO:0001774) | 3.10651871 |
| 50 | regulation of protein activation cascade (GO:2000257) | 3.09172024 |
| 51 | macrophage activation (GO:0042116) | 3.08087043 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.06687997 |
| 53 | kynurenine metabolic process (GO:0070189) | 3.04246838 |
| 54 | lysine catabolic process (GO:0006554) | 3.04240538 |
| 55 | lysine metabolic process (GO:0006553) | 3.04240538 |
| 56 | detection of bacterium (GO:0016045) | 3.03656184 |
| 57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01358002 |
| 58 | lipoprotein transport (GO:0042953) | 3.00974213 |
| 59 | detection of biotic stimulus (GO:0009595) | 2.97965224 |
| 60 | reverse cholesterol transport (GO:0043691) | 2.97191938 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96759612 |
| 62 | cysteine metabolic process (GO:0006534) | 2.96388970 |
| 63 | bile acid metabolic process (GO:0008206) | 2.96250370 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 2.95596841 |
| 65 | cellular extravasation (GO:0045123) | 2.94787882 |
| 66 | positive regulation of fatty acid oxidation (GO:0046321) | 2.94330649 |
| 67 | sulfur amino acid catabolic process (GO:0000098) | 2.93580265 |
| 68 | negative regulation of fibrinolysis (GO:0051918) | 2.92184584 |
| 69 | glyoxylate metabolic process (GO:0046487) | 2.91497047 |
| 70 | regulation of complement activation (GO:0030449) | 2.91414049 |
| 71 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.90840836 |
| 72 | glutamate secretion (GO:0014047) | 2.90645029 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.89035883 |
| 74 | synaptic vesicle maturation (GO:0016188) | 2.88890221 |
| 75 | hormone catabolic process (GO:0042447) | 2.88281721 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.86373520 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 2.86156604 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 2.86156604 |
| 79 | macromolecular complex remodeling (GO:0034367) | 2.86156604 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 2.84487494 |
| 81 | tryptophan catabolic process (GO:0006569) | 2.84444344 |
| 82 | indole-containing compound catabolic process (GO:0042436) | 2.84444344 |
| 83 | indolalkylamine catabolic process (GO:0046218) | 2.84444344 |
| 84 | drug catabolic process (GO:0042737) | 2.84360105 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 2.82310810 |
| 86 | fatty acid transmembrane transport (GO:1902001) | 2.79601986 |
| 87 | acetyl-CoA metabolic process (GO:0006084) | 2.78173417 |
| 88 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.77900012 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.77241292 |
| 90 | cellular glucuronidation (GO:0052695) | 2.77240858 |
| 91 | phospholipid homeostasis (GO:0055091) | 2.77019968 |
| 92 | protein carboxylation (GO:0018214) | 2.76771964 |
| 93 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.76771964 |
| 94 | angiotensin maturation (GO:0002003) | 2.75541453 |
| 95 | locomotory exploration behavior (GO:0035641) | 2.75096386 |
| 96 | regulation of fibrinolysis (GO:0051917) | 2.73536423 |
| 97 | tyrosine metabolic process (GO:0006570) | 2.71233689 |
| 98 | cholesterol efflux (GO:0033344) | 2.71091851 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 2.69747012 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 2.69718229 |
| 101 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.69590790 |
| 102 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.68975282 |
| 103 | regulation of cholesterol esterification (GO:0010872) | 2.68965865 |
| 104 | negative regulation of lipase activity (GO:0060192) | 2.68740694 |
| 105 | fatty acid beta-oxidation (GO:0006635) | 2.68479472 |
| 106 | phospholipid efflux (GO:0033700) | 2.68474591 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68259982 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 2.66736283 |
| 109 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.66474686 |
| 110 | regulation of sequestering of triglyceride (GO:0010889) | 2.65083839 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 2.64543191 |
| 112 | vocalization behavior (GO:0071625) | 2.64539976 |
| 113 | glycerolipid catabolic process (GO:0046503) | 2.63168790 |
| 114 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.63148979 |
| 115 | response to host immune response (GO:0052572) | 2.63035773 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.63035773 |
| 117 | intestinal absorption (GO:0050892) | 2.62865665 |
| 118 | synaptic vesicle exocytosis (GO:0016079) | 2.62286842 |
| 119 | tryptophan metabolic process (GO:0006568) | 2.62126433 |
| 120 | fatty acid oxidation (GO:0019395) | 2.61607650 |
| 121 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61268284 |
| 122 | protein-lipid complex assembly (GO:0065005) | 2.61069721 |
| 123 | bile acid and bile salt transport (GO:0015721) | 2.58836933 |
| 124 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.58505862 |
| 125 | fatty acid catabolic process (GO:0009062) | 2.58454820 |
| 126 | response to host (GO:0075136) | 2.58106591 |
| 127 | response to host defenses (GO:0052200) | 2.58106591 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58106591 |
| 129 | dicarboxylic acid catabolic process (GO:0043649) | 2.56973069 |
| 130 | fatty acid homeostasis (GO:0055089) | 2.56698549 |
| 131 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.56388693 |
| 132 | lipid oxidation (GO:0034440) | 2.56086579 |
| 133 | alanine transport (GO:0032328) | 2.55785625 |
| 134 | epoxygenase P450 pathway (GO:0019373) | 2.55132159 |
| 135 | triglyceride metabolic process (GO:0006641) | 2.55047697 |
| 136 | aspartate family amino acid catabolic process (GO:0009068) | 2.54956523 |
| 137 | alpha-amino acid catabolic process (GO:1901606) | 2.54642196 |
| 138 | amino-acid betaine metabolic process (GO:0006577) | 2.54288693 |
| 139 | coenzyme catabolic process (GO:0009109) | 2.53683972 |
| 140 | ketone body metabolic process (GO:1902224) | 2.52408545 |
| 141 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.52319382 |
| 142 | nucleobase catabolic process (GO:0046113) | 2.52271635 |
| 143 | monocarboxylic acid catabolic process (GO:0072329) | 2.51837682 |
| 144 | exogenous drug catabolic process (GO:0042738) | 2.51215961 |
| 145 | neurotransmitter secretion (GO:0007269) | 2.50987865 |
| 146 | homocysteine metabolic process (GO:0050667) | 2.50699649 |
| 147 | negative regulation of protein activation cascade (GO:2000258) | 2.48443092 |
| 148 | triglyceride biosynthetic process (GO:0019432) | 2.48115308 |
| 149 | regulation of cellular amide metabolic process (GO:0034248) | 2.47249757 |
| 150 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.47231188 |
| 151 | acylglycerol metabolic process (GO:0006639) | 2.47114987 |
| 152 | acyl-CoA biosynthetic process (GO:0071616) | 2.46847434 |
| 153 | thioester biosynthetic process (GO:0035384) | 2.46847434 |
| 154 | regulation of bile acid biosynthetic process (GO:0070857) | 2.46739999 |
| 155 | neutral lipid metabolic process (GO:0006638) | 2.45957470 |
| 156 | iron ion import (GO:0097286) | 2.43882660 |
| 157 | uronic acid metabolic process (GO:0006063) | 2.42980691 |
| 158 | glucuronate metabolic process (GO:0019585) | 2.42980691 |
| 159 | I-kappaB phosphorylation (GO:0007252) | 2.39855736 |
| 160 | B cell receptor signaling pathway (GO:0050853) | 2.39249217 |
| 161 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37804319 |
| 162 | response to peptidoglycan (GO:0032494) | 2.37404021 |
| 163 | COPII vesicle coating (GO:0048208) | 2.37111119 |
| 164 | embryonic process involved in female pregnancy (GO:0060136) | 2.36829757 |
| 165 | nerve growth factor signaling pathway (GO:0038180) | 2.36061837 |
| 166 | negative regulation of fatty acid transport (GO:2000192) | 2.33242949 |
| 167 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.29139260 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 2.28119516 |
| 169 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.28086144 |
| 170 | mRNA modification (GO:0016556) | 2.26409368 |
| 171 | regulation of humoral immune response (GO:0002920) | 2.25480294 |
| 172 | regulation of beta-amyloid formation (GO:1902003) | 2.24180768 |
| 173 | negative regulation of B cell mediated immunity (GO:0002713) | 2.22132919 |
| 174 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.22132919 |
| 175 | response to interleukin-15 (GO:0070672) | 2.21428556 |
| 176 | positive regulation of interferon-alpha production (GO:0032727) | 2.19950494 |
| 177 | neutrophil activation (GO:0042119) | 2.18686328 |
| 178 | phospholipid dephosphorylation (GO:0046839) | 2.17275302 |
| 179 | regulation of ARF protein signal transduction (GO:0032012) | 2.17223969 |
| 180 | early endosome to late endosome transport (GO:0045022) | 2.15858366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.64949955 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64370988 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.48922515 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44667627 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.05073197 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.04389578 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00750508 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.00351696 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.95127239 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77425047 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51033075 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.45582219 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.31626912 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.30370326 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23017517 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22253765 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21747356 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19195187 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.11371870 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03347753 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03269910 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00468700 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98897899 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98211719 |
| 25 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93178790 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92527245 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.89018376 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83818856 |
| 29 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.80732135 |
| 30 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.80732135 |
| 31 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78552865 |
| 32 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73634847 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70061322 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64710078 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64623057 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63188776 |
| 37 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62969488 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62441305 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62288989 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58244723 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56950761 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.56688997 |
| 43 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.53214428 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.51541300 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51126429 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51039228 |
| 47 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49357211 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49349323 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49164714 |
| 50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45149725 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42179966 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40562354 |
| 53 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.39803528 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39721628 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37484819 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36827599 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36143785 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36065622 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35383158 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35287210 |
| 61 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34883537 |
| 62 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33470849 |
| 63 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32757693 |
| 64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31157797 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30859800 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29666792 |
| 67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29300027 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27433485 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27294215 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26763946 |
| 71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26407101 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.25854087 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24680778 |
| 74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24647359 |
| 75 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24226964 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22945666 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22907413 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21772522 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20782671 |
| 80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20433107 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19974329 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19621201 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19257119 |
| 84 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17757747 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16866335 |
| 86 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16814954 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16482853 |
| 88 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15418834 |
| 89 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15376797 |
| 90 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14987243 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14510598 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14147494 |
| 93 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13673617 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12734795 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12319650 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12319650 |
| 97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12203279 |
| 98 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.11785226 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10925838 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10798343 |
| 101 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09461861 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09378862 |
| 103 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08284509 |
| 104 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07923060 |
| 105 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07876794 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06659500 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05568152 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05049448 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05047380 |
| 110 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.04964749 |
| 111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04882314 |
| 112 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03883090 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03048941 |
| 114 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.02844220 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02751282 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02014627 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01925646 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01925646 |
| 119 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01885182 |
| 120 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01549899 |
| 121 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01452768 |
| 122 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00572298 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00426788 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99779345 |
| 125 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99595289 |
| 126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99368582 |
| 127 | AR_19668381_ChIP-Seq_PC3_Human | 0.99173196 |
| 128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98941953 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98063411 |
| 130 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97478289 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97432985 |
| 132 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96855621 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96544177 |
| 134 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96381740 |
| 135 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96349568 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96287516 |
| 137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95727434 |
| 138 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95160241 |
| 139 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93673170 |
| 140 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93325999 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92530144 |
| 142 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92064051 |
| 143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92004740 |
| 144 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91122320 |
| 145 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90501956 |
| 146 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90372445 |
| 147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89945556 |
| 148 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89931453 |
| 149 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89552890 |
| 150 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88011760 |
| 151 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87879369 |
| 152 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87571825 |
| 153 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87144613 |
| 154 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85050215 |
| 155 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84432428 |
| 156 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84277094 |
| 157 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83589746 |
| 158 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81307661 |
| 159 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80606215 |
| 160 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80561103 |
| 161 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80193684 |
| 162 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.80077664 |
| 163 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79550609 |
| 164 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79075600 |
| 165 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78973222 |
| 166 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77357410 |
| 167 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.76616804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.12357196 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.98514076 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.75213831 |
| 4 | MP0005365_abnormal_bile_salt | 3.70260812 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.53086903 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.27139371 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.20171963 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.09078194 |
| 9 | MP0003724_increased_susceptibility_to | 3.07355749 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.97030244 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.75624394 |
| 12 | MP0005409_darkened_coat_color | 2.59380888 |
| 13 | MP0003252_abnormal_bile_duct | 2.57227662 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.34361353 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.20219140 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.18650307 |
| 17 | MP0004130_abnormal_muscle_cell | 2.16038257 |
| 18 | MP0004270_analgesia | 2.16028369 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.12163772 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.05113523 |
| 21 | MP0000015_abnormal_ear_pigmentation | 2.05057742 |
| 22 | MP0005670_abnormal_white_adipose | 2.03688811 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.94299512 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.93379409 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.92063871 |
| 26 | MP0003303_peritoneal_inflammation | 1.91961053 |
| 27 | MP0002009_preneoplasia | 1.91440038 |
| 28 | MP0005451_abnormal_body_composition | 1.91436241 |
| 29 | MP0005408_hypopigmentation | 1.90231291 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.90204323 |
| 31 | MP0003880_abnormal_central_pattern | 1.89467305 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.88758577 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.83031236 |
| 34 | MP0003329_amyloid_beta_deposits | 1.82157369 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.80698101 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.77807830 |
| 37 | MP0003436_decreased_susceptibility_to | 1.77169974 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.76350839 |
| 39 | MP0003690_abnormal_glial_cell | 1.75287251 |
| 40 | MP0009046_muscle_twitch | 1.74787989 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.74314416 |
| 42 | MP0005332_abnormal_amino_acid | 1.72478038 |
| 43 | MP0002822_catalepsy | 1.72248606 |
| 44 | MP0009745_abnormal_behavioral_response | 1.71871226 |
| 45 | MP0002064_seizures | 1.67647794 |
| 46 | MP0009840_abnormal_foam_cell | 1.63892710 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.62491445 |
| 48 | MP0005666_abnormal_adipose_tissue | 1.61004436 |
| 49 | MP0005083_abnormal_biliary_tract | 1.59509614 |
| 50 | MP0002419_abnormal_innate_immunity | 1.58810224 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.57096047 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.49440973 |
| 53 | MP0005535_abnormal_body_temperature | 1.48043252 |
| 54 | MP0003195_calcinosis | 1.47054496 |
| 55 | MP0009785_altered_susceptibility_to | 1.46837055 |
| 56 | MP0008260_abnormal_autophagy | 1.46755548 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.46136350 |
| 58 | MP0003828_pulmonary_edema | 1.45994654 |
| 59 | MP0000604_amyloidosis | 1.42693071 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.41007616 |
| 61 | MP0000685_abnormal_immune_system | 1.40969672 |
| 62 | MP0006082_CNS_inflammation | 1.40511630 |
| 63 | MP0001851_eye_inflammation | 1.39122798 |
| 64 | MP0004883_abnormal_blood_vessel | 1.37795691 |
| 65 | MP0002971_abnormal_brown_adipose | 1.37677520 |
| 66 | MP0003091_abnormal_cell_migration | 1.36734544 |
| 67 | MP0000371_diluted_coat_color | 1.36139251 |
| 68 | MP0001486_abnormal_startle_reflex | 1.35824879 |
| 69 | MP0002272_abnormal_nervous_system | 1.35002302 |
| 70 | MP0002006_tumorigenesis | 1.33698562 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.33694105 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.33568073 |
| 73 | MP0000609_abnormal_liver_physiology | 1.30691622 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.29661478 |
| 75 | MP0005164_abnormal_response_to | 1.28675031 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27259928 |
| 77 | MP0004484_altered_response_of | 1.27104449 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 1.25883385 |
| 79 | MP0005025_abnormal_response_to | 1.25733237 |
| 80 | MP0004185_abnormal_adipocyte_glucose | 1.23126653 |
| 81 | MP0000003_abnormal_adipose_tissue | 1.22498362 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 1.21588934 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.21053893 |
| 84 | MP0001800_abnormal_humoral_immune | 1.19912242 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.18660859 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.15251494 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 1.14662691 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.14426958 |
| 89 | MP0005334_abnormal_fat_pad | 1.14328425 |
| 90 | MP0003866_abnormal_defecation | 1.14126426 |
| 91 | MP0004924_abnormal_behavior | 1.12957399 |
| 92 | MP0005386_behavior/neurological_phenoty | 1.12957399 |
| 93 | MP0005448_abnormal_energy_balance | 1.11968646 |
| 94 | MP0004043_abnormal_pH_regulation | 1.11546504 |
| 95 | MP0002396_abnormal_hematopoietic_system | 1.11097246 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.10964611 |
| 97 | MP0001533_abnormal_skeleton_physiology | 1.10512557 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 1.07909890 |
| 99 | MP0003633_abnormal_nervous_system | 1.06421529 |
| 100 | MP0001968_abnormal_touch/_nociception | 1.04807422 |
| 101 | MP0005166_decreased_susceptibility_to | 1.04505236 |
| 102 | MP0001845_abnormal_inflammatory_respons | 1.02188613 |
| 103 | MP0005387_immune_system_phenotype | 1.01686365 |
| 104 | MP0001790_abnormal_immune_system | 1.01686365 |
| 105 | MP0008569_lethality_at_weaning | 1.01081879 |
| 106 | MP0001177_atelectasis | 1.00340716 |
| 107 | MP0005000_abnormal_immune_tolerance | 1.00336402 |
| 108 | MP0008469_abnormal_protein_level | 0.99755087 |
| 109 | MP0002723_abnormal_immune_serum | 0.99407455 |
| 110 | MP0003868_abnormal_feces_composition | 0.98877887 |
| 111 | MP0008057_abnormal_DNA_replication | 0.98038819 |
| 112 | MP0002452_abnormal_antigen_presenting | 0.97448823 |
| 113 | MP0005248_abnormal_Harderian_gland | 0.97248898 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.96789784 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.93982402 |
| 116 | MP0008874_decreased_physiological_sensi | 0.92207691 |
| 117 | MP0002067_abnormal_sensory_capabilities | 0.92041391 |
| 118 | MP0000751_myopathy | 0.91534913 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.91516105 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.90691759 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.89895617 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.89772493 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.88998520 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.88616917 |
| 125 | MP0001819_abnormal_immune_cell | 0.87048004 |
| 126 | MP0008872_abnormal_physiological_respon | 0.87026531 |
| 127 | MP0002090_abnormal_vision | 0.86255358 |
| 128 | MP0004381_abnormal_hair_follicle | 0.85293177 |
| 129 | MP0003763_abnormal_thymus_physiology | 0.84878412 |
| 130 | MP0005423_abnormal_somatic_nervous | 0.83015451 |
| 131 | MP0003631_nervous_system_phenotype | 0.82211734 |
| 132 | MP0002132_abnormal_respiratory_system | 0.82184552 |
| 133 | MP0001764_abnormal_homeostasis | 0.82065179 |
| 134 | MP0009115_abnormal_fat_cell | 0.81584714 |
| 135 | MP0004947_skin_inflammation | 0.78597039 |
| 136 | MP0000920_abnormal_myelination | 0.78425298 |
| 137 | MP0002066_abnormal_motor_capabilities/c | 0.76695502 |
| 138 | MP0003879_abnormal_hair_cell | 0.76365192 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.76209420 |
| 140 | MP0003075_altered_response_to | 0.75993031 |
| 141 | MP0008438_abnormal_cutaneous_collagen | 0.75462441 |
| 142 | MP0004215_abnormal_myocardial_fiber | 0.74471894 |
| 143 | MP0005551_abnormal_eye_electrophysiolog | 0.74367329 |
| 144 | MP0000858_altered_metastatic_potential | 0.72966810 |
| 145 | MP0004885_abnormal_endolymph | 0.72921095 |
| 146 | MP0001661_extended_life_span | 0.72778965 |
| 147 | MP0009764_decreased_sensitivity_to | 0.71528544 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.71505305 |
| 149 | MP0005310_abnormal_salivary_gland | 0.71324379 |
| 150 | MP0003566_abnormal_cell_adhesion | 0.71167873 |
| 151 | MP0001970_abnormal_pain_threshold | 0.70787573 |
| 152 | MP0006276_abnormal_autonomic_nervous | 0.69379963 |
| 153 | MP0002405_respiratory_system_inflammati | 0.68459901 |
| 154 | MP0003959_abnormal_lean_body | 0.68207326 |
| 155 | MP0003953_abnormal_hormone_level | 0.66956571 |
| 156 | MP0002229_neurodegeneration | 0.66415988 |
| 157 | MP0004811_abnormal_neuron_physiology | 0.64747263 |
| 158 | MP0006138_congestive_heart_failure | 0.63705348 |
| 159 | MP0003045_fibrosis | 0.61690065 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.61316938 |
| 161 | MP0002254_reproductive_system_inflammat | 0.60949272 |
| 162 | MP0009643_abnormal_urine_homeostasis | 0.60472722 |
| 163 | MP0003632_abnormal_nervous_system | 0.60428067 |
| 164 | MP0004085_abnormal_heartbeat | 0.60253595 |
| 165 | MP0005620_abnormal_muscle_contractility | 0.59648761 |
| 166 | MP0005167_abnormal_blood-brain_barrier | 0.59544278 |
| 167 | MP0005452_abnormal_adipose_tissue | 0.59102926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.64058491 |
| 2 | Xanthomatosis (HP:0000991) | 4.37861060 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.06544640 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.03497109 |
| 5 | Complement deficiency (HP:0004431) | 3.95118686 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.90193608 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.83599468 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.77849621 |
| 9 | Epidermoid cyst (HP:0200040) | 3.69627178 |
| 10 | Focal motor seizures (HP:0011153) | 3.53774018 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44556513 |
| 12 | Gingival bleeding (HP:0000225) | 3.40491536 |
| 13 | Myokymia (HP:0002411) | 3.39112845 |
| 14 | Ketosis (HP:0001946) | 3.30597716 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.25158702 |
| 16 | Orchitis (HP:0100796) | 3.24968133 |
| 17 | Peritonitis (HP:0002586) | 3.19863898 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.18194531 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.13535119 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.10209048 |
| 21 | Malnutrition (HP:0004395) | 3.07815604 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 3.07180224 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.07013273 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.05590290 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04987020 |
| 26 | Hyperglycinuria (HP:0003108) | 2.99988500 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.99929322 |
| 28 | Gingivitis (HP:0000230) | 2.98383246 |
| 29 | Ketoacidosis (HP:0001993) | 2.95706578 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.95691982 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95691982 |
| 32 | Optic neuritis (HP:0100653) | 2.95148862 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.95148862 |
| 34 | Hyperammonemia (HP:0001987) | 2.92269453 |
| 35 | Subacute progressive viral hepatitis (HP:0006572) | 2.92233405 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.89457864 |
| 37 | Skin nodule (HP:0200036) | 2.88141161 |
| 38 | Myositis (HP:0100614) | 2.86037019 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.81474315 |
| 40 | Focal seizures (HP:0007359) | 2.81118111 |
| 41 | Action tremor (HP:0002345) | 2.77631933 |
| 42 | Hyperglycinemia (HP:0002154) | 2.72144449 |
| 43 | Hypoglycemic coma (HP:0001325) | 2.70387771 |
| 44 | Oligomenorrhea (HP:0000876) | 2.68992292 |
| 45 | Steatorrhea (HP:0002570) | 2.67895823 |
| 46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.65657899 |
| 47 | Abnormality of complement system (HP:0005339) | 2.61274119 |
| 48 | Papillary thyroid carcinoma (HP:0002895) | 2.59808998 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.55949312 |
| 50 | Hypercholesterolemia (HP:0003124) | 2.51389838 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.50925046 |
| 52 | Visual hallucinations (HP:0002367) | 2.47238495 |
| 53 | Impaired social interactions (HP:0000735) | 2.46565451 |
| 54 | Abnormal social behavior (HP:0012433) | 2.46565451 |
| 55 | Intention tremor (HP:0002080) | 2.46450174 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.38440728 |
| 57 | Dysdiadochokinesis (HP:0002075) | 2.37269172 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37150107 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.37150107 |
| 60 | Cholecystitis (HP:0001082) | 2.36643669 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.36643669 |
| 62 | Hyperventilation (HP:0002883) | 2.34807214 |
| 63 | Dysmetric saccades (HP:0000641) | 2.34755611 |
| 64 | Glomerulonephritis (HP:0000099) | 2.31952299 |
| 65 | Status epilepticus (HP:0002133) | 2.31480718 |
| 66 | Chronic diarrhea (HP:0002028) | 2.27456051 |
| 67 | Fat malabsorption (HP:0002630) | 2.26752790 |
| 68 | Periodontitis (HP:0000704) | 2.25831673 |
| 69 | Scanning speech (HP:0002168) | 2.25717397 |
| 70 | Pulmonary embolism (HP:0002204) | 2.25649415 |
| 71 | Generalized tonic-clonic seizures (HP:0002069) | 2.25522390 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 2.25384500 |
| 73 | Pheochromocytoma (HP:0002666) | 2.24555149 |
| 74 | Torticollis (HP:0000473) | 2.23604439 |
| 75 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.22779297 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22364278 |
| 77 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22340480 |
| 78 | Arterial thrombosis (HP:0004420) | 2.21819485 |
| 79 | Blue irides (HP:0000635) | 2.21584505 |
| 80 | Absence seizures (HP:0002121) | 2.21399697 |
| 81 | Ocular albinism (HP:0001107) | 2.21369682 |
| 82 | Dysmetria (HP:0001310) | 2.18945320 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.18239547 |
| 84 | Postural instability (HP:0002172) | 2.17570558 |
| 85 | Atonic seizures (HP:0010819) | 2.17450893 |
| 86 | Insidious onset (HP:0003587) | 2.16049822 |
| 87 | Termporal pattern (HP:0011008) | 2.16049822 |
| 88 | Acanthocytosis (HP:0001927) | 2.15567466 |
| 89 | Poor eye contact (HP:0000817) | 2.15299455 |
| 90 | Increased CSF protein (HP:0002922) | 2.14382398 |
| 91 | Pigmentary retinal degeneration (HP:0001146) | 2.14151445 |
| 92 | Resting tremor (HP:0002322) | 2.13494244 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13326306 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13326306 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13326306 |
| 96 | Vascular calcification (HP:0004934) | 2.13173128 |
| 97 | Progressive cerebellar ataxia (HP:0002073) | 2.13018458 |
| 98 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.12362696 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.11561576 |
| 100 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08289588 |
| 101 | Abnormal eating behavior (HP:0100738) | 2.07570762 |
| 102 | Asymmetry of the thorax (HP:0001555) | 2.06538832 |
| 103 | Joint hemorrhage (HP:0005261) | 2.05922542 |
| 104 | Spontaneous hematomas (HP:0007420) | 2.05886316 |
| 105 | Recurrent skin infections (HP:0001581) | 2.05411396 |
| 106 | Vasculitis (HP:0002633) | 2.05267664 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 2.04759330 |
| 108 | Gout (HP:0001997) | 2.03951460 |
| 109 | Amyloidosis (HP:0011034) | 2.03682447 |
| 110 | Focal dystonia (HP:0004373) | 2.03382592 |
| 111 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.03261839 |
| 112 | Supranuclear gaze palsy (HP:0000605) | 2.02701385 |
| 113 | Generalized hypopigmentation of hair (HP:0011358) | 2.02650233 |
| 114 | Cholelithiasis (HP:0001081) | 2.02494308 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.02153686 |
| 116 | Epileptic encephalopathy (HP:0200134) | 2.01575382 |
| 117 | Polycythemia (HP:0001901) | 2.01347170 |
| 118 | Abnormality of purine metabolism (HP:0004352) | 2.00970803 |
| 119 | Craniofacial dystonia (HP:0012179) | 2.00198929 |
| 120 | Hypoglycemic seizures (HP:0002173) | 2.00093525 |
| 121 | Abnormality of the corticospinal tract (HP:0002492) | 1.99947788 |
| 122 | Turricephaly (HP:0000262) | 1.99753412 |
| 123 | Cardiovascular calcification (HP:0011915) | 1.98921543 |
| 124 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93866899 |
| 125 | Chest pain (HP:0100749) | 1.91937348 |
| 126 | Keratoconjunctivitis (HP:0001096) | 1.91771733 |
| 127 | Hydroxyprolinuria (HP:0003080) | 1.91530287 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.91530287 |
| 129 | Arterial tortuosity (HP:0005116) | 1.91095759 |
| 130 | Spontaneous abortion (HP:0005268) | 1.90719243 |
| 131 | Cerebral hemorrhage (HP:0001342) | 1.90347412 |
| 132 | Myocardial infarction (HP:0001658) | 1.89291041 |
| 133 | Nephritis (HP:0000123) | 1.89183063 |
| 134 | Osteomyelitis (HP:0002754) | 1.89079091 |
| 135 | Dysostosis multiplex (HP:0000943) | 1.88420361 |
| 136 | Coarse hair (HP:0002208) | 1.87180199 |
| 137 | Abnormality of the peritoneum (HP:0002585) | 1.86258494 |
| 138 | Abnormality of T cell number (HP:0011839) | 1.85373440 |
| 139 | Tetraplegia (HP:0002445) | 1.85307299 |
| 140 | Spastic gait (HP:0002064) | 1.85266936 |
| 141 | Dialeptic seizures (HP:0011146) | 1.84724922 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.84234661 |
| 143 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84234661 |
| 144 | Anxiety (HP:0000739) | 1.84200922 |
| 145 | Depression (HP:0000716) | 1.83741500 |
| 146 | Joint swelling (HP:0001386) | 1.83558299 |
| 147 | T lymphocytopenia (HP:0005403) | 1.83039031 |
| 148 | Urinary urgency (HP:0000012) | 1.81788971 |
| 149 | Abnormality of vitamin metabolism (HP:0100508) | 1.81182571 |
| 150 | Metabolic acidosis (HP:0001942) | 1.81050289 |
| 151 | Acanthosis nigricans (HP:0000956) | 1.80803110 |
| 152 | Impaired vibratory sensation (HP:0002495) | 1.80720153 |
| 153 | Hypertriglyceridemia (HP:0002155) | 1.80572542 |
| 154 | Thyroid carcinoma (HP:0002890) | 1.80435789 |
| 155 | Abnormal platelet volume (HP:0011876) | 1.79985604 |
| 156 | Mitral stenosis (HP:0001718) | 1.79905696 |
| 157 | Neuroendocrine neoplasm (HP:0100634) | 1.78947114 |
| 158 | Acute hepatic failure (HP:0006554) | 1.78151325 |
| 159 | Papilledema (HP:0001085) | 1.77936927 |
| 160 | Thickened calvaria (HP:0002684) | 1.77773440 |
| 161 | Prolonged bleeding time (HP:0003010) | 1.77714693 |
| 162 | Recurrent fungal infections (HP:0002841) | 1.76913929 |
| 163 | Epistaxis (HP:0000421) | 1.76114133 |
| 164 | Iris hypopigmentation (HP:0007730) | 1.75524310 |
| 165 | Viral hepatitis (HP:0006562) | 1.74261256 |
| 166 | Urticaria (HP:0001025) | 1.73334571 |
| 167 | Pulmonary infiltrates (HP:0002113) | 1.73100540 |
| 168 | Testicular neoplasm (HP:0010788) | 1.72576212 |
| 169 | Fair hair (HP:0002286) | 1.72492306 |
| 170 | Episodic fever (HP:0001954) | 1.71536943 |
| 171 | Meningitis (HP:0001287) | 1.71135773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 2.81185563 |
| 2 | BMPR2 | 2.71248954 |
| 3 | MAP3K9 | 2.63970744 |
| 4 | NTRK3 | 2.57999439 |
| 5 | MAP3K4 | 2.57647973 |
| 6 | MAP2K4 | 2.45572974 |
| 7 | FGFR3 | 2.36057369 |
| 8 | TYK2 | 2.34595879 |
| 9 | PRPF4B | 2.27526959 |
| 10 | DAPK2 | 2.24000509 |
| 11 | MAP2K3 | 2.19969808 |
| 12 | MAP3K14 | 2.11161674 |
| 13 | FRK | 2.07116316 |
| 14 | CAMK1G | 2.02867343 |
| 15 | STK24 | 2.01777110 |
| 16 | PAK6 | 1.96638331 |
| 17 | TRIB3 | 1.96245494 |
| 18 | BLK | 1.89206681 |
| 19 | YES1 | 1.88359251 |
| 20 | SIK1 | 1.85982433 |
| 21 | CAMK1D | 1.85652910 |
| 22 | FGFR2 | 1.81493993 |
| 23 | RIPK1 | 1.76144496 |
| 24 | MAP3K3 | 1.74111930 |
| 25 | KSR2 | 1.73466652 |
| 26 | IRAK4 | 1.72384036 |
| 27 | PRKD3 | 1.69553473 |
| 28 | MINK1 | 1.67110004 |
| 29 | ACVR1B | 1.66790967 |
| 30 | INSRR | 1.62754381 |
| 31 | CSK | 1.62490420 |
| 32 | NTRK1 | 1.60191341 |
| 33 | CAMKK1 | 1.59508270 |
| 34 | TRPM7 | 1.54004615 |
| 35 | BCKDK | 1.50816901 |
| 36 | MAP2K7 | 1.46685689 |
| 37 | MARK1 | 1.45427071 |
| 38 | MAP3K2 | 1.44035229 |
| 39 | LMTK2 | 1.42780181 |
| 40 | PDK4 | 1.32611961 |
| 41 | PDK3 | 1.32611961 |
| 42 | RET | 1.30362251 |
| 43 | JAK3 | 1.29901267 |
| 44 | ZAP70 | 1.21465884 |
| 45 | STK38 | 1.21432679 |
| 46 | ERBB3 | 1.18430217 |
| 47 | PDPK1 | 1.17681465 |
| 48 | AKT3 | 1.17363266 |
| 49 | OXSR1 | 1.17059827 |
| 50 | PRKCH | 1.16440290 |
| 51 | RIPK4 | 1.14188310 |
| 52 | PAK3 | 1.14108104 |
| 53 | CDK5 | 1.12399310 |
| 54 | PIK3CG | 1.11832416 |
| 55 | NEK9 | 1.09244431 |
| 56 | IRAK1 | 1.08246302 |
| 57 | CAMKK2 | 1.07148565 |
| 58 | SGK494 | 1.06367767 |
| 59 | SGK223 | 1.06367767 |
| 60 | KSR1 | 1.05928690 |
| 61 | PDK1 | 1.02628116 |
| 62 | SGK3 | 1.00921660 |
| 63 | EPHB1 | 1.00755927 |
| 64 | FGR | 0.99872929 |
| 65 | NTRK2 | 0.97229809 |
| 66 | WNK1 | 0.96256168 |
| 67 | STK39 | 0.94952986 |
| 68 | MST1R | 0.94595090 |
| 69 | GRK6 | 0.94157833 |
| 70 | EPHA3 | 0.93369040 |
| 71 | MAP3K7 | 0.92955718 |
| 72 | TEC | 0.89100101 |
| 73 | STK11 | 0.87889352 |
| 74 | EEF2K | 0.87604608 |
| 75 | SYK | 0.86750097 |
| 76 | PTK2B | 0.86384134 |
| 77 | FER | 0.86206370 |
| 78 | PINK1 | 0.86103191 |
| 79 | TYRO3 | 0.85342796 |
| 80 | ERN1 | 0.83970211 |
| 81 | TGFBR2 | 0.83368553 |
| 82 | FGFR4 | 0.82312848 |
| 83 | GRK5 | 0.82281297 |
| 84 | HCK | 0.81281033 |
| 85 | LATS2 | 0.80662854 |
| 86 | SGK2 | 0.80002629 |
| 87 | PRKCG | 0.79961321 |
| 88 | PKN2 | 0.79760675 |
| 89 | STK3 | 0.79483312 |
| 90 | FES | 0.79243940 |
| 91 | ERBB4 | 0.79137622 |
| 92 | PDGFRA | 0.75773549 |
| 93 | PHKG1 | 0.75600330 |
| 94 | PHKG2 | 0.75600330 |
| 95 | CAMK2A | 0.75206874 |
| 96 | SIK3 | 0.75060110 |
| 97 | TBK1 | 0.74051475 |
| 98 | BTK | 0.73833360 |
| 99 | CDK6 | 0.73708929 |
| 100 | STK38L | 0.73308338 |
| 101 | MAP2K1 | 0.73089231 |
| 102 | PRKAA2 | 0.72455230 |
| 103 | PRKG2 | 0.71637639 |
| 104 | IKBKE | 0.71635980 |
| 105 | BRD4 | 0.71321700 |
| 106 | MAP3K13 | 0.70956206 |
| 107 | PIK3CA | 0.69649685 |
| 108 | CAMK2B | 0.69534823 |
| 109 | CAMK2G | 0.69308220 |
| 110 | WNK4 | 0.69200775 |
| 111 | PTK6 | 0.68998788 |
| 112 | CDK19 | 0.67968652 |
| 113 | PRKCZ | 0.67836252 |
| 114 | IRAK2 | 0.67750014 |
| 115 | CAMK1 | 0.66798076 |
| 116 | PDGFRB | 0.66683906 |
| 117 | ICK | 0.66104367 |
| 118 | DDR2 | 0.66037218 |
| 119 | MAP3K12 | 0.65465570 |
| 120 | LATS1 | 0.64864383 |
| 121 | PDK2 | 0.62304251 |
| 122 | MET | 0.62070685 |
| 123 | PNCK | 0.61998429 |
| 124 | CAMK2D | 0.60430721 |
| 125 | SGK1 | 0.59809115 |
| 126 | MAPK11 | 0.59755581 |
| 127 | MELK | 0.59671584 |
| 128 | PRKAA1 | 0.58442192 |
| 129 | TAOK1 | 0.58275843 |
| 130 | CSNK1G2 | 0.58188738 |
| 131 | NEK6 | 0.57768496 |
| 132 | MAP3K1 | 0.57237312 |
| 133 | PTK2 | 0.57212787 |
| 134 | SIK2 | 0.56668529 |
| 135 | MAP3K5 | 0.55645597 |
| 136 | NLK | 0.55593667 |
| 137 | PRKACG | 0.55370087 |
| 138 | DAPK1 | 0.55085118 |
| 139 | MAP3K6 | 0.54622700 |
| 140 | PLK2 | 0.54342123 |
| 141 | JAK1 | 0.54018751 |
| 142 | JAK2 | 0.53552185 |
| 143 | RPS6KA3 | 0.52000969 |
| 144 | MARK2 | 0.51228258 |
| 145 | BMX | 0.51064126 |
| 146 | CSF1R | 0.50870795 |
| 147 | PRKD1 | 0.50287443 |
| 148 | LCK | 0.50268852 |
| 149 | SCYL2 | 0.49104998 |
| 150 | LYN | 0.48305216 |
| 151 | MAP2K6 | 0.46759738 |
| 152 | MATK | 0.45974272 |
| 153 | MAP4K1 | 0.45331843 |
| 154 | MARK3 | 0.44672865 |
| 155 | TAOK3 | 0.43457600 |
| 156 | FYN | 0.42994263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.75229680 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.79556865 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61287727 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46984097 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03638210 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97397401 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92673590 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.92392685 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90121298 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.89819427 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85085128 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83455471 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.82584639 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73258631 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72540051 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66681068 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56921144 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.56735754 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53607294 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50603404 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49318776 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.44112663 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41764916 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39588425 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33649979 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30591661 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.30428791 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28470991 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.23721489 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22880487 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22325537 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21722357 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.20384660 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.19673449 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.19620073 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18161242 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.18006245 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16776208 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14415721 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14272259 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12717725 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.11539665 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09965876 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06775256 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06190924 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.03559028 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.02332366 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02031053 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00681283 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99402198 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98844964 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98630739 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98589376 |
| 54 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.96699188 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95231663 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95218738 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94656453 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94004430 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 0.93737542 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93414895 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91682438 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91135312 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.91094829 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90970867 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90955434 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89569524 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.87869803 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.87706812 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.87250604 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86737013 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86641782 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86608011 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85801281 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85015084 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84745119 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84663826 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83478383 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.83317862 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.83260170 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.82230878 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81830537 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80645804 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80637203 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80380352 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80037359 |
| 86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78414321 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77353223 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76873304 |
| 89 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76743823 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.74802833 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74626986 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74533863 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74507468 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73890920 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73500995 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72808098 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71629001 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71418090 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.70360336 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70140783 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69897487 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68382453 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67468093 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67227184 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.66582608 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66576420 |
| 107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66276922 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.66237887 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66082853 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65300624 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65278951 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64383552 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64148287 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63801433 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.62545400 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62498870 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62248364 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60216422 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59402101 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58912578 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58669350 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.58381770 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58297776 |
| 124 | Hepatitis B_Homo sapiens_hsa05161 | 0.57741627 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57510404 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.57200742 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56703132 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56483044 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55497575 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55426828 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54989838 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.54756685 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54258588 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.53992349 |
| 135 | Taste transduction_Homo sapiens_hsa04742 | 0.52639490 |
| 136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51660498 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51087231 |
| 138 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51064678 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50410881 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49614990 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49581766 |
| 142 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49440809 |
| 143 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49368058 |
| 144 | Allograft rejection_Homo sapiens_hsa05330 | 0.49096269 |
| 145 | Malaria_Homo sapiens_hsa05144 | 0.48688058 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48665174 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48559624 |
| 148 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47988570 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47912430 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.46711484 |
| 151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43863243 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43332766 |
| 153 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42718054 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42601731 |
| 155 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40351952 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | 0.39825276 |
| 157 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39046232 |
| 158 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38361236 |
| 159 | Gap junction_Homo sapiens_hsa04540 | 0.37775677 |
| 160 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37237541 |
| 161 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36421046 |
| 162 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36068780 |

